Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.52
Price to sales ratio
0.34

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4307
MLSS
Milestone Scientific, Inc. Common Stock
0.50 USD-1.96%+6.38%+31.58%-13.79%44.37 M USD
4320
DXR
Daxor Corporation - Closed End Fund
10.24 USD+5.89%+2.20%-2.48%-25.47%42.97 M USD
4482
FEMY
Femasys Inc. - Common Stock
3.20 USD+14.70%+8.84%+13.07%+788.89%26.80 M USD
4543
RVP
Retractable Technologies, Inc. Common Stock
0.72 USD0.00%0.00%+7.46%+4.26%21.55 M USD

Frequently asked questions about Harvard Bioscience Inc

What is the Harvard Bioscience Inc stock price today?

The current price of Harvard Bioscience Inc (HBIO) is 7.93. Over the past 24 hours, the stock has changed by +0.38%. Follow the HBIO chart for real-time price dynamics.

What is the stock ticker of Harvard Bioscience Inc?

Harvard Bioscience Inc trades under the ticker HBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Harvard Bioscience Inc stock going up?

HBIO has changed by +6.44% over the last week, +31.29% over the last month, and +1486.00% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Harvard Bioscience Inc?

Harvard Bioscience Inc currently has a market capitalization of 36.1 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Harvard Bioscience Inc earnings last quarter?

Last quarter, Harvard Bioscience Inc reported earnings of -0.64 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Harvard Bioscience Inc revenue for the last quarter?

Harvard Bioscience Inc reported quarterly revenue of 22.73 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Harvard Bioscience Inc net income for the last quarter?

Harvard Bioscience Inc reported net income of -2.91 M for the last quarter. The previous quarter showed -3.42 M, which means net income changed by +15.01%.

How many employees does Harvard Bioscience Inc have?

As of the latest available data, Harvard Bioscience Inc has 339 employees. Workforce size can provide additional context about the company's scale and operations.

What is Harvard Bioscience Inc EBITDA?

Harvard Bioscience Inc EBITDA is 806 K, and its EBITDA margin is 3.55%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Harvard Bioscience Inc stock?

You can buy Harvard Bioscience Inc (HBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Harvard Bioscience Inc stock?

Investing in Harvard Bioscience Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HBIO chart and related analysis on metatrader.com as part of your research.

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

News